Guardant Health Stock Performance
| GH Stock | USD 94.42 8.68 8.42% |
The company retains a Market Volatility (i.e., Beta) of 1.42, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Guardant Health will likely underperform. At this point, Guardant Health has a negative expected return of -0.18%. Please make sure to check out Guardant Health's sortino ratio, semi variance, and the relationship between the standard deviation and value at risk , to decide if Guardant Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Guardant Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return (8.42) | Five Day Return (12.95) | Year To Date Return (7.19) | Ten Year Return 193.23 | All Time Return 193.23 |
1 | Disposition of 155 shares by Krognes Steve E. of Guardant Health subject to Rule 16b-3 | 11/28/2025 |
2 | Disposition of 2000 shares by Kumud Kalia of Guardant Health at 104.6021 subject to Rule 16b-3 | 12/10/2025 |
3 | Disposition of 23997 shares by Helmy Eltoukhy of Guardant Health subject to Rule 16b-3 | 12/31/2025 |
4 | Disposition of tradable shares by Terilyn Monroe of Guardant Health at 113.4397 subject to Rule 16b-3 | 01/07/2026 |
5 | Disposition of 17379 shares by Terilyn Monroe of Guardant Health subject to Rule 16b-3 | 01/15/2026 |
6 | Acquisition by Hidalgo Medina Manuel of 232 shares of Guardant Health subject to Rule 16b-3 | 01/16/2026 |
7 | Wall Street Has a Positive Opinion on Guardant Health | 01/23/2026 |
8 | Is Guardant Health Still Attractive After A 140 percent One Year Share Price Surge | 02/04/2026 |
9 | Acquisition by Kumud Kalia of 1995 shares of Guardant Health subject to Rule 16b-3 | 02/10/2026 |
10 | Disposition of 3696 shares by Kumud Kalia of Guardant Health subject to Rule 16b-3 | 02/11/2026 |
11 | Guardant Health Shares Slide as Principal Cuts Stake and Insiders Sell - Coinpaper | 02/12/2026 |
12 | Disposition of 250 shares by Tariq Musa of Guardant Health subject to Rule 16b-3 | 02/13/2026 |
13 | What Makes Guardant Health a Good Healthcare Holding | 02/17/2026 |
14 | Guardant Health Non-GAAP EPS of -0.50 misses by 0.03, revenue of 281.3M beats by 9.02M | 02/19/2026 |
15 | BTIG Research Forecasts Strong Price Appreciation for Guardant Health Stock | 02/20/2026 |
| Begin Period Cash Flow | 629.8 M | |
| Total Cashflows From Investing Activities | -627.2 M |
Guardant Health Relative Risk vs. Return Landscape
If you would invest 10,779 in Guardant Health on November 26, 2025 and sell it today you would lose (1,337) from holding Guardant Health or give up 12.4% of portfolio value over 90 days. Guardant Health is generating negative expected returns and assumes 2.9379% volatility on return distribution over the 90 days horizon. Put differently, 26% of stocks are less risky than Guardant on the basis of their historical return distribution, and some 99% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Guardant Health Target Price Odds to finish over Current Price
The tendency of Guardant Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 94.42 | 90 days | 94.42 | about 98.0 |
Based on a normal probability distribution, the odds of Guardant Health to move above the current price in 90 days from now is about 98.0 (This Guardant Health probability density function shows the probability of Guardant Stock to fall within a particular range of prices over 90 days) .
Guardant Health Price Density |
| Price |
Predictive Modules for Guardant Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Guardant Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Guardant Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Guardant Health is not an exception. The market had few large corrections towards the Guardant Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Guardant Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Guardant Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.09 | |
β | Beta against Dow Jones | 1.42 | |
σ | Overall volatility | 5.48 | |
Ir | Information ratio | -0.02 |
Guardant Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Guardant Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Guardant Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Guardant Health generated a negative expected return over the last 90 days | |
| The company generated the yearly revenue of 982.02 M. Annual Net Loss to common stockholders was (416.28 M) with gross profit of 633.01 M. | |
| Guardant Health reports about 853.69 M in cash with (184.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35. | |
| Guardant Health has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: BTIG Research Forecasts Strong Price Appreciation for Guardant Health Stock |
Guardant Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Guardant Stock often depends not only on the future outlook of the current and potential Guardant Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardant Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 125.4 M | |
| Cash And Short Term Investments | 1.2 B |
Guardant Health Fundamentals Growth
Guardant Stock prices reflect investors' perceptions of the future prospects and financial health of Guardant Health, and Guardant Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guardant Stock performance.
| Return On Equity | -45.84 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | (0.43) % | ||||
| Current Valuation | 14.14 B | ||||
| Shares Outstanding | 129.87 M | ||||
| Price To Earning | (12.01) X | ||||
| Price To Book | 55.67 X | ||||
| Price To Sales | 13.64 X | ||||
| Revenue | 982.02 M | ||||
| Gross Profit | 633.01 M | ||||
| EBITDA | (396.56 M) | ||||
| Net Income | (416.28 M) | ||||
| Cash And Equivalents | 853.69 M | ||||
| Cash Per Share | 8.35 X | ||||
| Total Debt | 1.68 B | ||||
| Debt To Equity | 4.32 % | ||||
| Current Ratio | 6.18 X | ||||
| Book Value Per Share | (0.76) X | ||||
| Cash Flow From Operations | (184.76 M) | ||||
| Earnings Per Share | (3.22) X | ||||
| Market Capitalization | 13.39 B | ||||
| Total Asset | 2.01 B | ||||
| Retained Earnings | (2.99 B) | ||||
| Working Capital | 829.53 M | ||||
| Current Asset | 219.68 M | ||||
| Current Liabilities | 24.24 M | ||||
About Guardant Health Performance
By evaluating Guardant Health's fundamental ratios, stakeholders can gain valuable insights into Guardant Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Guardant Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Guardant Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 89.81 | 69.23 | |
| Return On Tangible Assets | (0.22) | (0.23) | |
| Return On Capital Employed | (0.26) | (0.27) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | 4.19 | 4.40 |
Things to note about Guardant Health performance evaluation
Checking the ongoing alerts about Guardant Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Guardant Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Guardant Health generated a negative expected return over the last 90 days | |
| The company generated the yearly revenue of 982.02 M. Annual Net Loss to common stockholders was (416.28 M) with gross profit of 633.01 M. | |
| Guardant Health reports about 853.69 M in cash with (184.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.35. | |
| Guardant Health has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: BTIG Research Forecasts Strong Price Appreciation for Guardant Health Stock |
- Analyzing Guardant Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guardant Health's stock is overvalued or undervalued compared to its peers.
- Examining Guardant Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Guardant Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guardant Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Guardant Health's stock. These opinions can provide insight into Guardant Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |